Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Kaye currently holds 152 shares of Elevance Health, Inc. (ELV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Kaye has been a net seller of ELV stock. They have purchased $0 and sold $12.5M worth of shares.
Mark Kaye's most recent insider trade was on Feb 24, 2026, when they sold 152 shares at $0.00 per share.
Mark Kaye serves as Executive at Elevance Health, Inc. (ELV). They have executed 69 insider transactions totaling $12.5M over their tenure at the company.
Mark Kaye holds the position of Executive at Elevance Health, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Mark Kaye has shown a selling trading pattern, with $0 in total purchases and $12.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark Kaye was on Mar 1, 2022, when they sold $1.4M worth of MCO shares. This transaction involved 4,379 shares at $323.88 per share.
Mark Kaye currently owns 152 shares of Elevance Health, Inc. (ELV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Kaye's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Kaye has 69 Form 4 filings on record as an insider at Elevance Health, Inc..
Set alerts for Mark Kaye and 40,000+ other insiders.